Results 151 to 160 of about 908,554 (203)

Activating NTRK Family Fusion Gene Mutation [PDF]

, 2020
openaire   +1 more source

AMM : entrectinib et larotrectinib – cancers avec fusion NTRK [PDF]

Bulletin du Cancer, 2020
Delaye, Matthieu, Rodrigues, Manuel
openaire   +2 more sources

Identification of NTRK fusion genes: experience in Mexico

Gaceta Mexicana de Oncolog�a, 2023
Leticia Bornstein-Quevedo, Claudia Bautista-Wong, Zaira Mojica-González, Mario Gámez-Rosales, Katia Hop-García   +4 more
openaire   +1 more source

TRK Inhibition:A New Tumor-Agnostic Treatment Strategy [PDF]

, 2018
Kummar, Shivaani, Lassen, Ulrik N
core   +1 more source

Advances in cholangiocarcinoma research: Report from the third Cholangiocarcinoma Foundation Annual Conference [PDF]

, 2016
Chapman, William, et al,
core   +1 more source

JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.

Annals of Oncology, 2020
T. Yoshino, G. Pentheroudakis, S. Mishima, M. Overman, K. Yeh, E. Baba, Y. Naito, F. Calvo, Ashish Saxena, L. Chen, M. Takeda, A. Cervantes, H. Taniguchi, Kensaku Yoshida, Y. Kodera, Y. Kitagawa, J. Tabernero, H. Burris, J. Douillard   +18 more
semanticscholar   +1 more source

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors. [PDF]

Oncotarget, 2018
Sigal DS, Bhangoo MS, Hermel JA, Pavlick DC, Frampton G, Miller VA, Ross JS, Ali SM.   +7 more
europepmc   +1 more source

Efficacy of larotrectinib in pediatric cancers with <i>NTRK</i> gene fusions. [PDF]

Transl Pediatr
Houghton PJ, Bjornsti MA.
europepmc   +1 more source

Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. [PDF]

Cell Oncol (Dordr)
Shen Y, Peng Q, Wen J, Yang L, Zhu L, Chen Y, Liu Q, Wang L, Yao J, Li A, Wang M, Liu Z.   +11 more
europepmc   +1 more source